期刊文献+

阿魏酸钠抑制高糖诱导的系膜细胞增殖 被引量:5

Inhibition of sodium ferulate on the proliferation of mesangial cells induced by high glucose
下载PDF
导出
摘要 目的探讨阿魏酸钠(SF)对高糖诱导的原代培养系膜细胞(GMC)增殖的作用及其机制。方法原代培养肾小球系膜细胞,分为正常组、甘露醇组、高糖组、高糖加不同浓度SF组,分别于处理后24、48h收集细胞。用MTT法检测细胞增殖;流式细胞术测定cyclinD1和细胞周期;免疫细胞化学检测p53蛋白的表达。结果48h内,高糖促进GMC增殖,使GMC由G1期进入S期细胞比例增高;同时cyclinD1蛋白表达上调而p53蛋白的表达减少;SF能明显对抗高糖的这种作用,其作用随SF浓度的增加、作用时间的延长而加强。结论SF可能通过抑制cyclinD1蛋白表达和促进p53蛋白生成,从而抑制高糖诱导的GMC增殖。 Objective To investigate the effects and mechanism of sodium ferulate (SF)on the proliferation of mesangial cells induced by high glucose. Methods The primary glomerular mesangial cells were divided into normal, mannitol, high gloucose and high gloucose plus different concentration SF groups. Cells were collected at 24 and 48 h. Cell proliferation was measured by MTT assay, and cell cycle and cyclinD1 were measured through flow-cytometry, p53 protein expression was detected by immunecytochemistry. Results High glucose significantly promoted mesangial cell proliferation and up-regulated the expression of cyclinD1, and down-regulated expression of p53 within 48 h. SF inhibited mesangial cell proliferation induced by high glucose with concentration and time-depended manner. Conclusions SF can inhibit proliferation of mesangial cells induced by high glucose by suppressing the cydinD1 expression and increasing the level of p53 protein possibly.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第13期1641-1644,共4页 Chinese Journal of Gerontology
基金 教育部博士点专项基金(20060660001) 贵州省省长基金(2005-303)
关键词 系膜细胞 高葡萄糖 阿魏酸钠 细胞周期 CYCLIND1 p53 Mesangial cells High glucose Sodium ferulate CyclinD1 p53
  • 相关文献

参考文献8

  • 1Kanwar YS,Wada J,Sun L,et al.Diabetic nephropathy:mechanisms of renal disease progression[J].Exp Bio Med(Maywood),2008;233(1):4-11.
  • 2Gruden G,Perin PC,Camussi G.Insight on the pathogenesis of diabetic nephropathy from study of podocyte and mesangium cell biology[J].Curr Diabetes Rev,2005;1(1):27-40.
  • 3Sodhi CP,Phadke SA,Batlle D,et al.Hypoxia and high glucose cause exaggerated mesangial cell growth and collagen synthesis:role of osteopontin[J].Am J Physiol Renal Physiol,2001;208(4):667-74.
  • 4Wolf G.Cell cycle regulation in diabetic nephropathy[J].Kidney Int,2000;9(suppl77):S59-66.
  • 5Wahab NA,Weston BS,Roberts T,et al.Connective tissue growth factor and regulation of the mesangial cell cycle:role in cellular hypertrophy[J].J Am Soc Nephrol,2002;13(10):2437-45.
  • 6郑凤鸣,任跃忠,赵同峰.阿魏酸钠治疗糖尿病肾病的初步临床观察[J].中国中西医结合杂志,2005,25(5):419-421. 被引量:12
  • 7罗华,桂华珍,郭兵,肖瑛,石明隽,张国忠.大鼠肾小球系膜细胞原代培养与鉴定[J].贵阳医学院学报,2006,31(2):120-123. 被引量:8
  • 8Danesh FR,Sadeghi MM,Amro N,et al.3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway:implications for diabetic nephropathy[J].Proc Natl Acad Sci USA,2002;99(12):8301-5.

二级参考文献21

  • 1孙晓艳,安靓,傅博,李进.肾小球系膜细胞的分离和培养[J].第一军医大学学报,2003,23(8):795-797. 被引量:9
  • 2梅长林,张黎明,陈蕾.大鼠系膜细胞系的建立及鉴定[J].肾脏病与透析肾移植杂志,1996,5(6):90-92. 被引量:18
  • 3Barton M,Carmona R,Krieger JE,et al.Endothelin regulates angiotensin-converting enzyme in the mouse kidney. J Cardiovasc Pharmacol 2000;36(Suppl 1):S244-S247.
  • 4World Health Organization. Definition, diagnosis and classification of diabetes mellitus.Report of a WHO consulation.Geneva: World Health Organization, 1999.
  • 5Itoh Y, Nakai A,Kakizawa H,et al.Alteration of endothelin-1 concentration in STZ-induced diabetic rat nephropathy,effects of a PGI2 derivative.Horm Res 2001;56(5-6):165-171.
  • 6Peppa-Patrikiou M,Dracopoulou M,Dacout-Vouetakis C.Urinary endothelin in adolescents and young adults with insulin-dependent diabetes mellitus: relation to urinary albumin,blood pressure and other factors. Metabolism 1998;47(11):1408-1412.
  • 7Wolf G,Ziyadeh FN.Molecular mechanisms of diabetic renal hypertrophy.Kidney Int 1999;56:393-405.
  • 8Barton M,Shaw S,d'Uscio LV,et al.Angiotensin Ⅱ increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997;238:861(3)-865.
  • 9Dhein S,Hochreuther S,Aus Dem Spring C,et al.Longterm effects of the endothelin (A) receptor antagonist LU 135252 and the angiotensin converting enzyme inhibitor trandolapril on diabatic angiopathy and nephropathy in a chronictype I diabetes millitus rat model.J Pharmacol Exp Ther 2000;293(2):351--359.
  • 10Gross ML,Ritz E,Schoof A,et al.Renal damage in the SHR/N-cp type 2 diabetes model:comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker.Lab Invest 2003;83(9):1267-1277.

共引文献17

同被引文献30

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部